Committee to Conduct an Interim Study Concerning the Costs of Prescription Drugs (SB276)
Summary
Senate Bill 276 (2019) creates an interim committee to conduct a study concerning the costs of prescription drugs and the impact of rebates, price reductions, and other remuneration from manufacturers on prescription drug prices. The committee also examines opportunities and options for lowering the costs of prescription drugs to make those drugs more affordable for Nevada residents. The committee must report its findings and recommendations to the Legislative Committee on Health Care and the 2021 Session of the Nevada Legislature.